Efficacy And Safety Of Sunitinib In Women With Advanced Breast Cancer

Completed · Phase 2

Conditions studied: Breast Neoplasms

In brief

Patients with advanced breast cancer to receive sunitinib (Sutent) once daily until disease progression.

Key facts

Study ID

NCT00471276

Run by

Pfizer

People needed

83

Starts

2007-08-01

Expected to finish

2010-06-01

Last updated by the study team

2011-07-25

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Histologically or cytologically proven diagnosis of breast cancer
• Metastatic or locally recurrent disease that is, in the opinion of the investigator, not amenable to resection or radiation therapy
• Patients with at least one measurable lesion as per RECIST

You may not qualify if…

• Inflammatory breast cancer
• Prior treatment with VEGF inhibitors (unless in adjuvant setting at least 12 months ago)

Where it is running

• Pfizer Investigational Site — Bakersfield, California, United States
• Pfizer Investigational Site — Burbank, California, United States
• Pfizer Investigational Site — Fountain Valley, California, United States
• Pfizer Investigational Site — Hawthorne, California, United States
• Pfizer Investigational Site — Long Beach, California, United States
• Pfizer Investigational Site — Boynton Beach, Florida, United States
• Pfizer Investigational Site — Zion, Illinois, United States
• Pfizer Investigational Site — Louisville, Kentucky, United States
• Pfizer Investigational Site — Kalamazoo, Michigan, United States
• Pfizer Investigational Site — Maple Grove, Minnesota, United States
• Pfizer Investigational Site — Minneapolis, Minnesota, United States
• Pfizer Investigational Site — Minneapolis, Minnesota, United States
• Pfizer Investigational Site — Columbia, Missouri, United States
• Pfizer Investigational Site — Asheville, North Carolina, United States
• Pfizer Investigational Site — Chapel Hill, North Carolina, United States
• Pfizer Investigational Site — Kernersville, North Carolina, United States
• Pfizer Investigational Site — Lexington, North Carolina, United States
• Pfizer Investigational Site — North Wilkesboro, North Carolina, United States
• Pfizer Investigational Site — Winston-Salem, North Carolina, United States
• Pfizer Investigational Site — Bismarck, North Dakota, United States
• Pfizer Investigational Site — Franklin, Tennessee, United States
• Pfizer Investigational Site — Gallatin, Tennessee, United States
• Pfizer Investigational Site — Hermitage, Tennessee, United States
• Pfizer Investigational Site — Lebanon, Tennessee, United States
• Pfizer Investigational Site — Murfreesboro, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.